Cleopatra Rx Development announced it raised $250,000 in an initial filing from an offering of $2 Million

Company

Location

About

Cleopatra RX provides women who have cognitive difficulties from menopause with cutting-edge treatments and supplements to eliminate brain fog and give them a clearer mind. The key to cognitive decline curing menopause is to be proactive, not reactive, when it comes to brain health. Estrogen and progesterone are vital hormones that protect against brain aging, neurodegeneration and brain atrophy. At the onset of menopause, these hormones drop sharply causing a range of symptoms including night sweats, hot flashes, mood swings, and brain fog. Developed by Neuroscientist and World-Renowned Expert in Brain Health, Rhonda R. Voskuhl, M.D. Rhonda Voskuhl, M.D. is a research scientist and professor of neurology at UCLA. Director of the Brain Research Institute (BRI). Her discovery of estrogen loss and its effect on cognition, was identified during her extensive research on cognitive function in individuals with multiple sclerosis. Menopause affects every woman differently. The list of symptoms that may occur during perimenopause and menopause is long. One of the more significant effects involves cognitive difficulties, also known as “brain fog”. Brain fog is characterized by a decline in active memory, long-term memory, and the ability to focus. The PearlPAK™* Advantage PearlPAK™ is a treatment designed to actively slow down degenerative effects in the brain caused by perimenopause and menopause. *PearlPAK™️ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and is used to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product for use as a drug/routine system and/or treatment.